STRM.BIO

About:

STRM.BIO is a biotechnology company that uses extracellular vesicles to deliver gene therapy in a more efficient and practical manner.

Website: https://strm.bio/

Twitter/X: STRMbio

Top Investors: Bill & Melinda Gates Foundation, NYBC Ventures, NCATS

Description:

STRM.BIO is a biotechnology company that uses extracellular vesicles to deliver gene therapy in a more efficient, safe, and practical manner. STRM.BIO aims to fulfill the promise of gene therapy by using extracellular vesicles to deliver treatment directly to the patient. The natural carriers of nucleic acids and proteins with innate targeting capabilities, the ability to be mass-produced on a large scale commercially, and low immunogenicity.

Total Funding Amount:

$2.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2019-01-01

Founders:

Jonathan Thon

Number of Employees:

1-10

Last Funding Date:

2023-10-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai